posted
SARASOTA, Fla., Jan. 27 /PRNewswire/ -- DNAPrint(TM) genomics, Inc. (OTC Bulletin Board: DNAP)(DNAPrint(TM) or the "Company") today introduced a new version of its popular ANCESTRYbyDNA(TM) 2.0 test for the genetic determination of BioGeographical Ancestry (BGA) admixture. The new test, "ANCESTRYbyDNA(TM) 2.5" provides increased power and enhanced sensitivity for genealogists because it is powered by 175 rather than 71 Ancestry Informative Markers (AIMs). The test is an augmented version of ANCESTRYbyDNA(TM) 2.0; 104 new AIMs were added to the core set of 71 used in the old test. Like the 2.0 version, ANCESTRYbyDNA(TM) 2.5 provides a customer's proportional Native American, East Asian, Indo-European, and West Sub-Saharan African BGA, but the increased number of markers allow for more sensitive and accurate determinations of low levels of admixture (such as that which may have been contributed by a single great grandparent). The enhanced sensitivity and efficiency allowed DNAPrint(TM) to also upgrade the presentation of results for the 2.5 version. The human genome has millions of markers, or genetic variations, but only 1-2% of these markers (0.002% of the genome) are ancestry informative. Because the AIMs measured by the test are among the genomes best, and due to the enhanced coverage of 8 AIMs per average chromosome, ANCESTRYbyDNA(TM) 2.5 represents the most powerful test of its kind ever developed. The new test sells for $219 per test. Customers who purchased the 2.0 version will receive an upgrade to 2.5 at a reduced rate of $158. The new test has been added to the www.ancestrybydna.com website. The Company is typing samples from discrete populations, such as groups of individuals who identify with a single ethnic or tribal group. The new website provides data from simulations that address the accuracy and precision of the ANCESTRYbyDNA(TM) tests. New data will be added to the website continuously as it is produced, allowing customers an empirical frame of reference for interpreting their results.
About DNAPrint(TM) genomics, Inc. DNAPrint(TM) genomics, Inc., ("DNAPrint(TM)" or the "Company"), is a genomics science company focused on the sale of proprietary genetic testing products and services. The Company's core technologies for efficiently targeting single nucleotide polymorphisms ("SNPs") enable it to provide predictive genetic tests at a significant cost advantage over its competitors. The Company has identified and patented the maps of certain SNPs with wide commercial applications called Ancestry Informative Markers ("AIMS"). The Company believes that AIMs are the key for unlocking the relationship between common variants and common anthropometric, disease and drug response traits. Effectively mapping disease and drug response sequences could lead to the development of clinical classifiers for improving drug development, personalizing drug use and empowering forensics investigations. The Company's patented AIMs are integral to the Company's strategy of offering DNA tests that provide valuable predictive results, including a person's physical characteristics, Biogeographical Ancestry ("BGA"), and predisposition to respond to certain pharmaceutical drugs. The Company's tests target four distinct markets -- forensics, consumer, pharmacogenomics (predicting drug response) and outsourced screening services. The Company is traded on the Nasdaq OTC Bulletin Board under the ticker symbol: DNAP. For more information about the company, please visit www.dnaprint.com.
All statements in this press release that are not historical are forward- looking statements within the meaning of Section 21E of the Securities Exchange Act as amended. Such statements are subject to risks and uncertainties that could cause actual results to differ materially from those projected, including, but not limited to, uncertainties relating to technologies, product development, manufacturing, market acceptance, cost and pricing of DNAPrint's(TM) products, dependence on collaborations and partners, regulatory approvals, competition, intellectual property of others, and patent protection and litigation. DNAPrint(TM) genomics, Inc. expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in DNAPrint's(TM) expectations with regard thereto or any change in events, conditions, or circumstances on which any such statements are based.
Media and Press Contacts Richard Gabriel DNAPrint(TM) genomics, Inc. CEO/President (941) 366-3400
SOURCE DNAPrint(TM) genomics, Inc. -0- 01/27/2004 /CONTACT: Richard Gabriel, CEO and President, DNAPrint(TM) genomics, Inc., +1-941-366-3400/ /Web site: http://www.dnaprint.com http://www.ancestrybydna.com / (DNAP)
CO: DNAPrint(TM) genomics, Inc. ST: Florida IN: MTC OTC SU: PDT
posted
there's great news on DNAP on OTCCharts.com, but I don't know how to get it here.
Posts: 173 | From: Lakeland FL USA | Registered: Jan 2004
| IP: Logged |
posted
I figured it out...finally. Here's the latest:
2004-01-28 08:58:27
DNAWitness(TM) Used To Guide The Investigation Of The '97 Rape And Murder Of Susannah Chase
***
SARASOTA, Fla., Jan. 28 /PRNewswire-FirstCall/ -- DNAPrint(TM) genomics (OTC Bulletin Board: DNAP) of Sarasota, FL confirmed that its DNAWitness(TM) test was strategically employed in an investigation by the Boulder, Colorado Police Department. Susannah Chase, 23, was brutally beaten and raped in December of 1997. Her body, as well as a DNA specimen, was found several days later. A representative of the Boulder Police Department has stated, "DNAPrint(TM) reported that the DNA investigators submitted is indicative of someone exhibiting features that are common to Hispanics or Native Americans. This information will assist detectives with prioritizing tips and possibly generate more investigative leads." DNA is commonly left at crime scenes, but until DNAPrint(TM) developed DNAWitness(TM), no ancestral or physical information could be reliably read from that DNA (other than gender). The genetic heritage of an individual cannot be accurately inferred from standard DNA tests. DNAWitness(TM) is powered by 175 of the human genome's best Ancestry Informative Markers (AIMs) and measures an individual's ancestry admixture from his or her DNA. From simulations and direct observations, it is known that DNAWitness(TM) results are precise to within a few percent, depending on the type of admixture present. Standard DNA testing provides a unique identifier from the crime scene DNA, but in this case, the crime scene DNA did not match any of the profiles in the FBI's CODIS database, making the identification of the suspect impossible at this time. Detectives continued their quest to learn about the donor of the DNA at the crime scene and their search led investigators to DNAPrint(TM) genomics, which is the first, and so far only, company able to offer this new type of DNA analysis. The test was applied by investigators to infer physical information about the suspect from the crime scene DNA, allowing them to focus precious investigative resources on high-value leads possibly related to the crime. Forensic validation studies of DNAWitness(TM) have been performed by the San Diego Police Department Crime Lab, the National Center for Forensic Science and the Broward County Crime Lab. In July 2003, a report in the Journal of Forensic Science provided the scientific rationale and results of studies related to DNAWitness(TM), and the test has since been covered by Popular Science, US News and World Report, the New York Times and national ABC and CBS news programs. DNAPrint(TM) genomics has successfully determined the ancestral background of over 5,000 individuals. "We are working with detectives on cases that have gone cold or are at a standstill," said Richard Gabriel, CEO and President of DNAPrint(TM) genomics, Inc. "We encourage all law enforcement officers to contact us. In this case, as in others, when DNAWitness(TM) has been used, the scope of the investigation has been focused, and resources will be more efficiently deployed. DNAWitness(TM) is proving to save time and resources -- and possibly lives -- by contributing valuable information about a suspect's ancestry. If there is a crime scene sample of DNA, DNAWitness(TM) can help re-direct or focus the investigation. Prior to this test, this case would remain unsolved until the murderer is caught committing another crime and that convicted felon's DNA is loaded into the CODIS system." "The test costs $1,000, but given the man hours this test can save and direction it can provide to an investigation where all other leads have gone cold, it's a reasonable price. The price is not much different from the expense incurred interviewing human eyewitnesses, yet the information provided is better than what most eyewitnesses can provide," said Tony Frudakis, PhD and CSO of the company. "Though our test can accurately distinguish between an individual of mainly Native American/European admixture (such as a Hispanic) from one of mainly European/East Asian admixture (such as an Asian American), a human from across the street might be hard pressed to do so reliably. This test is the only one of its kind. We have worked hard over the last four years building the test and validating it." He continued, "The test is a presumptive test that can be used by investigators to get a basic description out on the wire to other investigators and departments. It is an investigator's tool, not an identity tool. Once the pool of suspects has been narrowed down, then the standard DNA identity testing can be performed, under court order if necessary, to substantiate the potential guilt or innocence of an individual suspect." "I know if it were my daughter or son that had been murdered or raped, I would want this test run," said Zach Gaskin, Technical Director of Forensics. "I frequently give lectures on how our test works and how to use it. DNAWitness(TM) is becoming known as a reliable test for law enforcement across the country and abroad, allowing them to narrow their field of suspects rapidly. Because DNAWitness(TM) is a presumptive DNA test providing information as to how the donor of the DNA sample is likely to appear or not appear, essentially producing an out-of-focus photo, it will not likely meet the same scrutiny in the courtroom as the human identification tests that match a suspect to a crime scene sample. Nevertheless, we treat the evidence in accordance with policies and procedures followed by the American Society of Crime Laboratory Directors Lab Accreditation Board. It is important to note that the current human identification DNA tests performed by crime labs, known as STR tests, can only provide gender when you have no suspect to compare the evidence to. STR testing for criminal cases does require ASCLD/LAB certification because it actually identifies the individual as the person present at the crime scene." Gaskin went on to say, "DNAWitness(TM) provides a general description of the person, not a match, which we leave to the crime labs. But DNAWitness(TM) is an extremely valuable tool for helping detectives narrow the suspect list and focus their resources on leads that are more in line with the crime scene evidence." About DNAPrint(TM) genomics, Inc. DNAPrint(TM) genomics, Inc. uses proprietary human genome research methods to develop and sell genomic-based services. The Company introduced ANCESTRYbyDNA(TM) in the consumer market and DNAWitness(TM) in the forensic market in 2003. DNAPrint(TM) is developing products in the pharmacogenomic market and has a disease gene discovery program. The Company is traded on the NASDAQ OTC Bulletin Board under the ticker symbol: DNAP. For more information about the company, please visit www.dnaprint.com. All statements in this press release that are not historical are forward- looking statements within the meaning of Section 21E of the Securities Exchange Act as amended. Such statements are subject to risks and uncertainties that could cause actual results to differ materially from those projected, including, but not limited to, uncertainties relating to technologies, product development, manufacturing, market acceptance, cost and pricing of DNAPrint's(TM) products, dependence on collaborations and partners, regulatory approvals, competition, intellectual property of others, and patent protection and litigation. DNAPrint(TM) genomics, Inc. expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in DNAPrint's(TM) expectations with regard thereto or any change in events, conditions, or circumstances on which any such statements are based. Media and Press Contacts Richard Gabriel DNAPrint(TM) genomics, Inc. CEO/President (941) 366-3400 SOURCE DNAPrint genomics, Inc. -0- 01/28/2004 /CONTACT: Richard Gabriel, CEO - President, DNAPrint(TM) genomics, +1-941-366-3400/ /Web site: http://www.dnaprint.com/ (DNAP) CO: DNAPrint genomics, Inc.; Boulder Police Department ST: Florida, Colorado IN: MTC OTC SU:
Posts: 173 | From: Lakeland FL USA | Registered: Jan 2004
| IP: Logged |
posted
This is a very good long play. A lot of big people have money in this company. Potentially they can change how the medical and florensic field works.
Posts: 973 | From: usa | Registered: Aug 2003
| IP: Logged |
posted
Im still holding. I am in the green, but not by much. Any new word on this Dog?
Posts: 104 | From: Cleveland Ohio | Registered: Nov 2003
| IP: Logged |
posted
Nothing new. This thing will eventually break. Too much goin' for it. Lot of high profile stories such as "Joan Benet Ramsey" case associated with this stock, but in my opinion it's the geneology area where they will really get the most attention.
UBBFriend: Email this page to someone!
Printer-friendly view of this topic
